These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 25280757

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
    Keenan K, Avolio J, Rueckes-Nilges C, Tullis E, Gonska T, Naehrlich L.
    J Cyst Fibros; 2015 May; 14(3):310-6. PubMed ID: 25300456
    [Abstract] [Full Text] [Related]

  • 23. Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis.
    Ahrens RC, Standaert TA, Launspach J, Han SH, Teresi ME, Aitken ML, Kelley TJ, Hilliard KA, Milgram LJ, Konstan MW, Weatherly MR, McCarty NA.
    Pediatr Pulmonol; 2002 Feb; 33(2):142-50. PubMed ID: 11802252
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. β-adrenergic sweat secretion as a diagnostic test for cystic fibrosis.
    Quinton P, Molyneux L, Ip W, Dupuis A, Avolio J, Tullis E, Conrad D, Shamsuddin AK, Durie P, Gonska T.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):732-9. PubMed ID: 22859523
    [Abstract] [Full Text] [Related]

  • 26. Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.
    Accurso FJ, Van Goor F, Zha J, Stone AJ, Dong Q, Ordonez CL, Rowe SM, Clancy JP, Konstan MW, Hoch HE, Heltshe SL, Ramsey BW, Campbell PW, Ashlock MA.
    J Cyst Fibros; 2014 Mar 15; 13(2):139-47. PubMed ID: 24660233
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
    Burgel PR, Fajac I, Hubert D, Grenet D, Stremler N, Roussey M, Siret D, Languepin J, Mely L, Fanton A, Labbé A, Domblides P, Vic P, Dagorne M, Reynaud-Gaubert M, Counil F, Varaigne F, Bienvenu T, Bellis G, Dusser D.
    Clin Genet; 2010 Apr 15; 77(4):355-64. PubMed ID: 19843100
    [Abstract] [Full Text] [Related]

  • 30. Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis.
    Sousa M, Servidoni MF, Vinagre AM, Ramalho AS, Bonadia LC, Felício V, Ribeiro MA, Uliyakina I, Marson FA, Kmit A, Cardoso SR, Ribeiro JD, Bertuzzo CS, Sousa L, Kunzelmann K, Ribeiro AF, Amaral MD.
    PLoS One; 2012 Apr 15; 7(10):e47708. PubMed ID: 23082198
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Assessing accuracy of testing and diagnosis in cystic fibrosis.
    Barillaro M, Gonska T.
    Expert Rev Respir Med; 2023 May 15; 17(5):337-349. PubMed ID: 37190981
    [Abstract] [Full Text] [Related]

  • 34. β-adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
    Zampoli M, Verstraete J, Nguyen-Khoa T, Sermet-Gaudelus I, Zar HJ, Gonska T, Morrow BM.
    Pediatr Pulmonol; 2023 Jan 15; 58(1):187-196. PubMed ID: 36193559
    [Abstract] [Full Text] [Related]

  • 35. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE, Macek M, Fulmer-Smentek SB, Egan MM, Schwiebert E, Guggino W, Moss R, Cutting GR.
    Hum Mol Genet; 1998 Apr 15; 7(4):729-35. PubMed ID: 9499426
    [Abstract] [Full Text] [Related]

  • 36. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F, Ballmann M, Bronsveld I, Dörk T, Gallati S, Laabs U, Derichs N, Ritzka M, Posselt HG, Harms HK, Griese M, Blau H, Mastella G, Bijman J, Veeze H, Tümmler B.
    J Med Genet; 2008 Jan 15; 45(1):47-54. PubMed ID: 18178635
    [Abstract] [Full Text] [Related]

  • 37. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM.
    Clin Genet; 2016 May 15; 89(5):539-49. PubMed ID: 26671754
    [Abstract] [Full Text] [Related]

  • 38. [Cystic fibrosis and normal sweat chloride values: a case-report].
    Lebecque P, Leal T, Godding V.
    Rev Mal Respir; 2001 Sep 15; 18(4 Pt 1):443-5. PubMed ID: 11547256
    [Abstract] [Full Text] [Related]

  • 39. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.
    Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, Jones CW, Boydston JA, Clancy JP, Bowen LE, Accurso FJ, Blalock JE, Dransfield MT, Rowe SM.
    Am J Respir Crit Care Med; 2013 Dec 01; 188(11):1321-30. PubMed ID: 24040746
    [Abstract] [Full Text] [Related]

  • 40. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
    Clancy JP, Bebök Z, Ruiz F, King C, Jones J, Walker L, Greer H, Hong J, Wing L, Macaluso M, Lyrene R, Sorscher EJ, Bedwell DM.
    Am J Respir Crit Care Med; 2001 Jun 01; 163(7):1683-92. PubMed ID: 11401894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.